Stocks
Bristol-Myers (BMY) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 8.29 | 1.64 | 1.51 | 48.9 | 9.62 | 10.5 | ||
| Changes by years, y/y, % | -77% | -80% | -8% | +3 146% | -80% | -23.0% | |||
Bristol-Myers. EV/EBITDA
Bristol-Myers. EV/EBITDA, changes, %
Bristol-Myers (BMY) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| EV/EBITDA | ? | 8.72 | 8.48 | 9.61 | 10.6 | 8.98 | 10.5 | |
| Changes by years, y/y, % | -5% | -71% | -80% | +6% | +3% | |||
| Changes by quarters, q/q, % | -14% | -3% | +13% | +11% | -16% | |||
